Varex Imaging (NASDAQ:VREX – Get Free Report) is expected to issue its Q4 2026 results after the market closes on Tuesday, November 17th. Analysts expect Varex Imaging to post earnings of $0.33 per share and revenue of $229.79 million for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2026 earnings results page for the latest details on the call scheduled for Tuesday, November 17, 2026 at 4:00 PM ET.
Varex Imaging (NASDAQ:VREX – Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.21 by $0.10. The company had revenue of $210.50 million for the quarter, compared to the consensus estimate of $215.50 million. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. On average, analysts expect Varex Imaging to post $1.04 EPS for the current fiscal year and $1.10 EPS for the next fiscal year.
Varex Imaging Stock Up 0.1%
NASDAQ:VREX opened at $18.45 on Tuesday. The firm has a market cap of $783.39 million, a P/E ratio of 35.48 and a beta of 1.02. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.53 and a current ratio of 3.38. Varex Imaging has a fifty-two week low of $9.09 and a fifty-two week high of $18.63. The firm has a 50-day simple moving average of $18.46 and a two-hundred day simple moving average of $13.76.
Insider Transactions at Varex Imaging
Analysts Set New Price Targets
A number of equities analysts recently weighed in on VREX shares. Weiss Ratings upgraded shares of Varex Imaging from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Zacks Research cut Varex Imaging from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 27th. B. Riley Financial downgraded Varex Imaging from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. CJS Securities lowered Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 17th. Finally, Oppenheimer lowered Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 10th. Seven equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat, Varex Imaging presently has a consensus rating of “Hold” and an average price target of $16.88.
Check Out Our Latest Stock Analysis on Varex Imaging
Varex Imaging Company Profile
Varex Imaging Corporation develops and manufactures X-ray imaging components used in medical, industrial, and security applications. Its products are incorporated into systems that support diagnostic imaging, radiation therapy, baggage inspection, cargo screening, and other imaging processes.
The company’s product portfolio includes X-ray tubes, digital detectors, image-processing software, high-voltage connectors, and other components for X-ray imaging systems. Varex also provides software and services designed to support image quality, system performance, and equipment integration.
Varex serves equipment manufacturers and other customers worldwide, with applications spanning healthcare, industrial inspection, and security screening.
Featured Stories
- Five stocks we like better than Varex Imaging
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
